BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.52B |
| 2 |
Visa
V
|
+$442M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$391M |
| 4 |
DuPont de Nemours
DD
|
+$296M |
| 5 |
NVIDIA
NVDA
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$643M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$407M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$245M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$243M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.3% |
| 2 | Consumer Discretionary | 8.84% |
| 3 | Healthcare | 6.65% |
| 4 | Financials | 5.53% |
| 5 | Industrials | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $207K | ﹤0.01% |
3,300
-25,291
| -88% | -$1.58M |
|
2902
BioLife Solutions
BLFS
$1.72B
| $207K | ﹤0.01% |
9,349
-3,100
| -25% | -$65.3K |
|
2903
CALL
MongoDB
MDB
$38B
| $205K | ﹤0.01% |
5
-25
| -83% | -$7.29K |
|
2904
MakeMyTrip
MMYT
$5.67B
| $205K | ﹤0.01% |
7,599
-478
| -6% | -$12.3K |
|
2905
German American Bancorp
GABC
$1.91B
| $205K | ﹤0.01% |
7,536
-7,731
| -51% | -$225K |
|
|
BRKL
2906
DELISTED
Brookline Bancorp
BRKL
| $205K | ﹤0.01% |
23,434
-24,430
| -51% | -$223K |
|
|
HSII
2907
DELISTED
Heidrick & Struggles
HSII
| $204K | ﹤0.01% |
7,725
-9,575
| -55% | -$253K |
|
2908
Equity Bancshares
EQBK
$1.07B
| $204K | ﹤0.01% |
8,968
+577
| +7% | +$13.5K |
|
|
ATRI
2909
DELISTED
Atrion Corp
ATRI
| $204K | ﹤0.01% |
361
-212
| -37% | -$124K |
|
|
FBMS
2910
DELISTED
The First Bancshares, Inc.
FBMS
| $204K | ﹤0.01% |
7,902
-5,133
| -39% | -$131K |
|
|
ONC
2911
BeOne Medicines Ltd
ONC
$40.6B
| $204K | ﹤0.01% |
1,143
-469
| -29% | -$108K |
|
2912
Amneal Pharmaceuticals
AMRX
$6.15B
| $204K | ﹤0.01% |
65,719
-56,875
| -46% | -$121K |
|
|
TBI
2913
Trueblue
TBI
$302M
| $203K | ﹤0.01% |
11,471
-11,454
| -50% | -$194K |
|
2914
Oppenheimer Holdings
OPY
$1.23B
| $201K | ﹤0.01% |
5,012
-15,051
| -75% | -$575K |
|
2915
Heritage Financial
HFWA
$1.22B
| $201K | ﹤0.01% |
12,406
-11,013
| -47% | -$192K |
|
2916
Adaptive Biotechnologies
ADPT
$3.89B
| $200K | ﹤0.01% |
29,807
-35,695
| -54% | -$265K |
|
|
FFIC
2917
DELISTED
Flushing Financial
FFIC
| $200K | ﹤0.01% |
16,272
-14,254
| -47% | -$179K |
|
2918
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.59B
| $197K | ﹤0.01% |
6,851
-786
| -10% | -$20.9K |
|
|
TWOU
2919
DELISTED
2U Inc
TWOU
| $196K | ﹤0.01% |
1,624
-345
| -18% | -$45.9K |
|
|
GOOD
2920
Gladstone Commercial Corp
GOOD
$641M
| $195K | ﹤0.01% |
15,794
-9,632
| -38% | -$116K |
|
2921
LSB Industries
LXU
$711M
| $194K | ﹤0.01% |
19,686
-30,307
| -61% | -$290K |
|
2922
Stoneridge
SRI
$197M
| $194K | ﹤0.01% |
10,270
-7,759
| -43% | -$136K |
|
|
WSR
2923
DELISTED
Whitestone REIT
WSR
| $193K | ﹤0.01% |
19,932
-14,740
| -43% | -$133K |
|
2924
Ribbon Communications
RBBN
$372M
| $192K | ﹤0.01% |
68,771
-1,781
| -3% | -$4.94K |
|
2925
Accuray
ARAY
$32.9M
| $192K | ﹤0.01% |
49,577
+38,370
| +342% | +$133K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2023 Portfolio in Review
As of Q2 2023, BNP Paribas Financial Markets held 4,079 positions worth $80B, up 12% from $71.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets's Q2 2023 filing shows 263 new, 1,328 increased, 1,932 reduced and 164 closed positions. Its largest new stake was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M. The largest sale was Invesco QQQ Trust, an estimated $643M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- BNP Paribas Financial Markets's largest Q2 2023 buy was Direxion NASDAQ-100 Equal Weighted Index ETF: 200,000 shares worth $15.4M.
- BNP Paribas Financial Markets added most to Alibaba in Q2 2023, an estimated $1.52B increase.
- BNP Paribas Financial Markets's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $643M.
- BNP Paribas Financial Markets fully exited iShares Russell Mid-Cap Growth ETF in Q2 2023, selling an estimated $35.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $80B portfolio in Q2 2023.
- BNP Paribas Financial Markets opened 263 new positions and closed 164 in Q2 2023.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $80B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.